Sclerotherapy versus β blockade: Unanticipated anomalies of experimental design
Open Access
- 30 November 1993
- journal article
- editorial
- Published by Elsevier in Gastroenterology
- Vol. 105 (5) , 1575-1577
- https://doi.org/10.1016/0016-5085(93)90171-8
Abstract
No abstract availableThis publication has 12 references indexed in Scilit:
- Propranolol versus sclerotherapy in preventing variceal rebleeding: A randomized controlled trialGastroenterology, 1993
- A Fallacy of Intention-to-Treat AnalysisGastroenterology, 1991
- Propranolol in the prevention of the first hemorrhage from esophagogastric varices: A multicenter, randomized clinical trialHepatology, 1991
- Acute and chronic hemodynamic effects of propranolol in unselected cirrhotic patientsHepatology, 1987
- Propranolol for prevention of recurrent gastrointestinal bleeding in patients with cirrhosis: A prospective study of factors associated with rebleedingHepatology, 1987
- Failure of haemodynamic measurements to predict recurrent gastrointestinal bleeding in cirrhotic patients receiving propranololJournal of Hepatology, 1987
- Meta-analysis in clinical trialsControlled Clinical Trials, 1986
- Propranolol for Portal HypertensionArchives of internal medicine (1960), 1985
- Effects of Propranolol on Azygos Venous Blood Flow and Hepatic and Systemic Hemodynamics in CirrhosisHepatology, 1984
- Transection of the oesophagus for bleeding oesophageal varicesBritish Journal of Surgery, 1973